# Tolinapant efficacy in a subset of triple negative breast cancers

> **NIH NIH U54** · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2022 · $200,000

## Abstract

Project Summary/Abstract
N/A

## Key facts

- **NIH application ID:** 10581272
- **Project number:** 3U54CA224076-04S2
- **Recipient organization:** UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
- **Principal Investigator:** Michael T. Lewis
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $200,000
- **Award type:** 3
- **Project period:** 2017-09-25 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10581272

## Citation

> US National Institutes of Health, RePORTER application 10581272, Tolinapant efficacy in a subset of triple negative breast cancers (3U54CA224076-04S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10581272. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*